CORCEPT THERAPEUTICS INC
public$CORT View Live Feed →
Total Raised
--
Contracts
--
Patents
1
PAC Giving
--
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
TREATMENT OF ADRENOCORTICAL CARCINOMA WITH SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS (SGRMS) AND ANTIBODY CHECKPOINT INHIBITORS
US 12648943 Jun 9, 2026
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Congressional Trades in $CORT
No disclosed congressional trades found in $CORT.
Insider Trades (Form 4)
SELLDirector
WILSON JAMES N
$882,98610,000 shares Jul 17, 2026
SELLChief Financial Officer
Mokari Atabak
$4,370,51280,000 shares Jul 17, 2026
GIFTChief Business Officer
Robb Gary Charles
600 shares Jul 9, 2026
SELLChief Development Officer
Guyer William
$2,295,53040,000 shares Jul 8, 2026
SELLChief Development Officer
Guyer William
$1,845,00040,000 shares Jun 4, 2026
GIFTDirector
WILSON JAMES N
910,078 shares May 29, 2026
Key People
Mokari Atabak
Chief Financial Officer
Insider
Guyer William
Chief Development Officer
Insider
WILSON JAMES N
Director
BoardInsider
Robb Gary Charles
Chief Business Officer
Insider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro